PTH and Hypercalcemia: Findings from another meta-analysis of randomized controlled trials had suggested that treatment of vitamin D compounds was associated with increased risk of hypercalcemia and hyperphosphatemia while inconsistently reducing parathyroid hormone (PTH) levels.